Edition:
United States

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

15.27USD
17 Feb 2017
Change (% chg)

$0.31 (+2.07%)
Prev Close
$14.96
Open
$14.90
Day's High
$15.30
Day's Low
$14.74
Volume
96,073
Avg. Vol
95,888
52-wk High
$23.73
52-wk Low
$9.24

NLNK.OQ

Chart for NLNK.OQ

About

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $444.89
Shares Outstanding(Mil.): 29.13
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 47.80 29.39
EPS (TTM): -3.23 -- --
ROI: -51.60 -4.08 13.06
ROE: -53.93 4.84 14.19

BRIEF-NewLink Genetics Q3 loss $0.54/shr

* NewLink Genetics Corp says expects to have approximately $132 million in cash and equivalents on December 31, 2016

Nov 01 2016

BRIEF-Newlink Genetics awarded $25 mln contract from BARDA for investigational Ebola Zaire vaccine (V920)

* Newlink Genetics awarded $25 million contract from BARDA for investigational Ebola Zaire vaccine (V920) Source text for Eikon: Further company coverage:

Oct 04 2016

More From Around the Web

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,513 -30.00
Pfizer Inc. (PFE.N) $33.62 0.00
Novartis AG (NOVN.S) CHF76.90 -0.10
Merck & Co., Inc. (MRK.N) $65.39 +0.13
Roche Holding Ltd. (ROG.S) CHF244.40 +0.90
Roche Holding Ltd. (RO.S) CHF247.80 +1.50
Abbott Laboratories (ABT.N) $44.69 +0.49
Sanofi SA (SASY.PA) €81.08 -0.41
AstraZeneca plc (AZN.L) 4,581.00 -14.00
GlaxoSmithKline plc (GSK.L) 1,634.61 -4.89

Earnings vs. Estimates